The Linda and Jack Gill Center for Biomolecular Science is extremely proud and cannot wait for September 2021 to present the following five scientists with the Transformative Investigator Award for their impressive contributions to neuroscience research performed on Cannabis.
School of Medicine of Ribeirao Preto-University of Sao Paulo
Research Summary: Interested in investigating the role of atypical neurotransmitters (nitric oxide and endocannabinoids) in anxiety and mood control and the effects of cannabidiol, a non-psychotomimetic component on Cannabis sativa, in neuropsychiatric disorders
Additional information on Dr. Guimaraes's research
Massachusetts General Hospital / Harvard Medical School
Research Summary: Interests include the role of diet in epilepsy treatment, genotype-phenotype correlation in TSC, the role of epilepsy surgery in management of intractable epilepsy, outcomes following infantile spasms, and neuropsychological profiles in relationship to tuber number and location in TSC.
Additional information on Dr. Thiele's research
University of Cagliari (Italy)
Research Summary: Interested in understanding neurobiological underpinnings (e.g., adaptations of both mesocorticolimbic dopamine pathway and endocannabinoid system) of resilience and susceptibility to neuropsychiatric disorders (e.g., substance use disorder, antisocial behavior, anxiety, and depression).
Additional information on Dr. Melis's research
Hotchkiss Brain Institute at University of Calgary
Research Summary: Interested in determining the role of the endocannabinoid system in the effects of stress on a) neuroendocrine function; b) emotional behavior; c) energy balance and metabolism; d) neuroinflammation and neurodegeneration. This is achieved through a systems approach incorporating a range of neuroscientific techniques ranging from cellular/biochemical to behavioral.
Additional information on Dr. Hill's research
Addiction Institute, Icahn School of Medicine at Mount Sinai
Research Summary: Investigating the neurobiology underlying addiction disorders and related psychiatric illnesses. A translational approach is used to examine molecular and neurochemical events in the human brain and comparable animal models in order to ascertain neurobiological correlates of behavior.
Additional information on Dr. Hurd's researchPlease save the date and plan to join us on Wednesday, September 29, 2021 for the 2021 Gill Symposium and Awards.
If you have any questions, please contact us!
